Top Markets
#1 0G 0G +23.70%
#2 Axelar Axelar +21.97%
#3 Cysic Cysic +21.57%
#4 Zora Zora +21.03%
#5 SAFEcoin SAFEcoin +19.60%
#6 Full Moon Full Moon +18.95%
#7 StonkBroker StonkBroker +16.85%
#8 AI XOVIA AI XOVIA +16.64%
#9 Merlin's Seal BTC Merlin's Seal BTC +16.61%
#10 ADO Protocol ADO Protocol +15.25%
Coin of the day
0G 0G
Settings
Language
ENGLISH
Currency
USD
Theme
Nanjing Hicin Pharmaceutical Co., Ltd. Nanjing Hicin Pharmaceutical Co., Ltd.

Nanjing Hicin Pharmaceutical Co., Ltd.

300584
Rank in Stocks #12878
Nanjing Hicin Pharmaceutical Co., Ltd. (NHPC), established in 2003 and... Nanjing Hicin Pharmaceutical Co., Ltd. (NHPC), established in 2003 and headquartered in Nanjing, China, operates as a comprehensive enterprise specializing in the research, development, production, marketing, and distribution of pharmaceutical preparations and synthetic chemicals within China. The company boasts a diverse product portfolio, addressing various therapeutic areas such as antivirals, antibiotics, endocrine regulators, gastrointestinal treatments, orthopedic medications, cardiovascular and cerebrovascular drugs, and immunomodulatory agents. Beyond its core pharmaceutical activities, NHPC also provides technology transfer services. On an international scale, Nanjing Hicin Pharmaceutical Co., Ltd. is a supplier of Active Pharmaceutical Ingredients (APIs). Its export offerings specifically include injectable forms of omeprazole sodium and cefepime hydrochloride, along with lansoprazole tablets, which reach markets across South Asia, South America, and Europe.
Share Price
$4.51
Market Cap
$540.82M
Change (1 day)
-2.42%
Change (1 year)
-43.50%
Country
CN
Trade Nanjing Hicin Pharmaceutical Co., Ltd. (300584)

Category

Healthcare
Earnings for Nanjing Hicin Pharmaceutical Co., Ltd. (300584)
Earnings in 2026 TTM: 0
According to Nanjing Hicin Pharmaceutical Co., Ltd. latest financial reports the company's current earnings are 0. In 2026 the company made an earning of 0, equal to its 2026 earnings that were of 0. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Earnings history for Nanjing Hicin Pharmaceutical Co., Ltd. from 2026 to 2026
Earnings at the end of each year
Year Earnings Change
Not enough data for the provided dates.
Earnings for similar companies or competitors
Company Earnings Earnings Difference Country
MERCK Kommanditgesellschaft auf Aktien MERCK Kommanditgesellschaft auf Aktien
MERCK Kommanditgesellschaft auf Aktien
MER.SW
- -
DE
Merck KGaA Merck KGaA
Merck KGaA
MRK.DE
- -
DE
Takeda Pharmaceutical Company Limited Takeda Pharmaceutical Company Limited
Takeda Pharmaceutical Company Limited
4502.T
- -
JP
Galderma Group AG Galderma Group AG
Galderma Group AG
GALD.SW
- -
CH
Sun Pharmaceutical Industries Limited Sun Pharmaceutical Industries Limited
Sun Pharmaceutical Industries Limited
SUNPHARMA.NS
$1.76B -
IN